Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

GISSI-HF investigators

doi:10.1016/s0140-6736(08)61239-8

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(08)61239-8 ◽

2008 ◽

Vol 372 (9645) ◽

pp. 1223-1230 ◽

Cited By ~ 828

Author(s):

GISSI-HF investigators

Keyword(s):

Heart Failure ◽

Fatty Acids ◽

Chronic Heart Failure ◽

Polyunsaturated Fatty Acids ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1124183.581324 ◽

2009 ◽

Author(s):

John Augoustides ◽

Insung Chung

Keyword(s):

Heart Failure ◽

Fatty Acids ◽

Chronic Heart Failure ◽

Polyunsaturated Fatty Acids ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717297963.792752819 ◽

2012 ◽

Author(s):

David Taylor ◽

Ethan Anderson

Keyword(s):

Heart Failure ◽

Fatty Acids ◽

Chronic Heart Failure ◽

Left Ventricular ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Systolic Left Ventricular Function ◽

Markers Of Inflammation ◽

Dose Dependent

Download Full-text

A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes

European Journal of Heart Failure ◽

10.1002/ejhf.1656 ◽

2019 ◽

Vol 22 (9) ◽

pp. 1628-1637 ◽

Cited By ~ 8

Author(s):

Anders Hostrup Larsen ◽

Niels Jessen ◽

Helene Nørrelund ◽

Lars Poulsen Tolbod ◽

Hendrik Johannes Harms ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Heart Failure Patients ◽

Insulin Resistant ◽

Myocardial Efficiency

Download Full-text

The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)

American Heart Journal ◽

10.1016/j.ahj.2020.09.020 ◽

2021 ◽

Vol 231 ◽

pp. 137-146

Author(s):

Henrik Wiggers ◽

Lars Køber ◽

Gunnar Gislason ◽

Morten Schou ◽

Mikael Kjær Poulsen ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Isosorbide Dinitrate ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Factorial Trial

Download Full-text

Beneficial effect of n-3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: a randomized, double blind, placebo-controlled trial

Scandinavian Journal of Rheumatology ◽

10.1080/03009742.2017.1287304 ◽

2017 ◽

Vol 47 (1) ◽

pp. 27-36 ◽

Cited By ~ 13

Author(s):

S Kristensen ◽

EB Schmidt ◽

A Schlemmer ◽

C Rasmussen ◽

MB Johansen ◽

...

Keyword(s):

Fatty Acids ◽

Psoriatic Arthritis ◽

Polyunsaturated Fatty Acids ◽

Beneficial Effect ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Analgesic Use

Download Full-text

Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

Clinical Nutrition ◽

10.1016/j.clnu.2015.05.001 ◽

2016 ◽

Vol 35 (3) ◽

pp. 578-586 ◽

Cited By ~ 44

Author(s):

Monize Aydar Nogueira ◽

Claudia Pinto Oliveira ◽

Venâncio Avancini Ferreira Alves ◽

José Tadeu Stefano ◽

Lívia Samara dos Reis Rodrigues ◽

...

Keyword(s):

Fatty Acids ◽

Polyunsaturated Fatty Acids ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Alcoholic Steatohepatitis

Download Full-text

Influence of angiotensin converting enzyme inhibition on exercise performance and clinical symptoms in chronic heart failure: a multicentre, double-blind, placebo-controlled trial

European Heart Journal ◽

10.1093/eurheartj/14.suppl_c.18 ◽

1993 ◽

Vol 14 (suppl C) ◽

pp. 18-23 ◽

Cited By ~ 12

Author(s):

L. Dossegger ◽

E. Aldor ◽

M. G. Baird ◽

S. Braun ◽

J. G. F. Cleland ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Angiotensin Converting Enzyme ◽

Clinical Symptoms ◽

Controlled Trial ◽

Angiotensin Converting Enzyme Inhibition ◽

Converting Enzyme ◽

Double Blind ◽

Double Blind Placebo ◽

Converting Enzyme Inhibition

Download Full-text

A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome)

Medicine ◽

10.1097/md.0000000000020271 ◽

2020 ◽

Vol 99 (21) ◽

pp. e20271 ◽

Cited By ~ 1

Author(s):

Lijun Guo ◽

Hui Yuan ◽

Dawu Zhang ◽

Jian Zhang ◽

Qi Hua ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Deficiency Syndrome ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Kidney Yang Deficiency

Download Full-text

Oil supplementation with a special combination of n-3 and n-6 long-chain polyunsaturated fatty acids does not protect for exercise induced asthma: a double-blind placebo-controlled trial

Lipids in Health and Disease ◽

10.1186/s12944-020-01343-2 ◽

2020 ◽

Vol 19 (1) ◽

Author(s):

M. Dreßler ◽

D. Fussbroich ◽

L. Böhler ◽

E. Herrmann ◽

N. Benker ◽

...

Keyword(s):

Fatty Acids ◽

Polyunsaturated Fatty Acids ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Exercise Induced ◽

Long Chain

Download Full-text

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(08)61240-4 ◽

2008 ◽

Vol 372 (9645) ◽

pp. 1231-1239 ◽

Cited By ~ 669

Author(s):

GISSI-HF investigators

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text